|
Anticancer Inc
pan02-gfp mouse pancreatic cancer cells ![]() Pan02 Gfp Mouse Pancreatic Cancer Cells, supplied by Anticancer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kpc+mouse+pancreatic+cancer+cells/pan02+gfp+mouse+pancreatic+cancer+cells/pmc07790874-132-0-8 Average 90 stars, based on 1 article reviews
pan02-gfp mouse pancreatic cancer cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
China Center for Type Culture Collection
mouse pancreatic cancer cell line pan02 x100165 ![]() Mouse Pancreatic Cancer Cell Line Pan02 X100165, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kpc+mouse+pancreatic+cancer+cells/mouse+pancreatic+cancer+cell+line+pan02+x100165/pmc08924000-205-14-40 Average 90 stars, based on 1 article reviews
mouse pancreatic cancer cell line pan02 x100165 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
iCell Bioscience Inc
mouse pancreatic cancer cell line panc02 ![]() Mouse Pancreatic Cancer Cell Line Panc02, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kpc+mouse+pancreatic+cancer+cells/mouse+pancreatic+cancer+cell+line+panc02/pm39261658-227-1-12 Average 90 stars, based on 1 article reviews
mouse pancreatic cancer cell line panc02 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Inserm Transfert
cancer bearing mice mouse pancreatic adenocarcinoma pk4a cells ![]() Cancer Bearing Mice Mouse Pancreatic Adenocarcinoma Pk4a Cells, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kpc+mouse+pancreatic+cancer+cells/adenocarcinoma+bearing+cancer+cells+mice+mouse+pancreatic+pk4a/us12465660-329-14-27 Average 86 stars, based on 1 article reviews
cancer bearing mice mouse pancreatic adenocarcinoma pk4a cells - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Molecular cancer therapeutics
Article Title: Recombinant orthopoxvirus primes colon cancer for checkpoint inhibitor and cross-primes T cells for anti-tumor and anti-viral immunity
doi: 10.1158/1535-7163.MCT-20-0405
Figure Lengend Snippet: A. Following the regression of treated MC38-Luc tumors, tumor growth after rechallenge with MC38-Luc cells is plotted by the original treatment group with volume in mm3. B. Survival curve demonstrating long-term survival of all but one mouse in regressed groups versus the death of all mice in naïve group C. Treatment plan showing that mice with regressed tumors after CF33-hNIS-ΔF14.5 treatment were rechallenged with MC38-Luc 2 months post-regression, and then rechallenged again, with MC38 on one flank and Pan02-GFP murine pancreas cells on the other D. Growth of Pan02-GFP but not MC38-Luc allografts suggests tumor antigen-specific anti-tumor immunity. Stat: Log-rank (Mantel-Cox test) *= p < 0.05
Article Snippet:
Techniques:
Journal: Nature Cell Biology
Article Title: Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1–mucin pathway
doi: 10.1038/s41556-022-00857-4
Figure Lengend Snippet: a , The expression of TET1-3 from AsPC-1 cells was determined by real-time PCR. b , TET1, TET2, TET3 (green color) and DAPI immunostaining in CCC-HPE-2, PANC-1, AsPC-1 and BxPC-3 cells. The mean fluorescence intensity (MFI) of TET1-3 was calculated by Image J. Scale bar, 5 μm. c , Western blot analysis of GSDME and TET2 expression from SGCTR and TET2 -SGs- PANC-1 or AsPC-1 cells. d , The expression of GSDME in SGCTR or TET2 -SGs was detected by real-time PCR. e , The knockout efficiency of GSDME in PANC-1, AsPC-1 or BxPC-3 cells was determined by western blot. f , The expression of GSDME in vector or Flag-GSDME-overexpressing PANC-1, AsPC-1 or BxPC-3 were determined by western blot. g , h , SGCTR or GSDME -SGs- PANC-1 cells (2 × 10 6 ) were subcutaneously injected into mice. Tumor growth was measured (g, n = 6/group). Tumors were presented photographically (h, left, n = 4/group) or weighed (h, right). i , j , SGCTR, GSDME -SGs or GSDME -SG/Flag- GSDME -PANC-1 cells (i, 5 × 10 5 cells) or AsPC-1 cells (j, 2.5 × 10 5 cells) were orthotopically injected into mice. Tumors were presented photographically (left) or weighed (right) (i, n = 5/group; j, n = 6/group). k , The knockout efficiency of Gsdme in Pan02 cells was determined by western blot. l , SGCTR or Gsdme -SGs-Pan02 cells (1 × 10 6 cells) were orthotopic injected into the pancreas of C57BL/6 mice. 40 days after injection, tumors were presented photographically (left) and weighted (right) (n = 4/group). The normal pancreas was served as control. Scale bar, 1 cm. m , The peripheral lymphocytes from humanized mice were analyzed by FACS using an anti-human CD45 antibody before the subsequent animal experiments (n = 6). n , SGCTR and GSDME -SG-AsPC-1 cells (2.5 × 10 5 cells) were orthotopic injected into the pancreas of humanized mice. Tumors were presented photographically (left) and weighted (right) (n = 6/group). Scale bar, 1 cm. In a-c and f , n = 3 biological independent experiments. ** P < 0.01, *** P < 0.001, by two-tailed one-way ANOVA Bonferroni’s test ( a , d , h-j , l and n ) or two-tailed student’s t-test ( b ). The data represent mean ± SD.
Article Snippet: The human pancreatic cancer cell lines PANC-1 (X100160), AsPC-1 (X100459) and BxPC-3 (X100441), the
Techniques: Expressing, Real-time Polymerase Chain Reaction, Immunostaining, Fluorescence, Western Blot, Knock-Out, Plasmid Preparation, Injection, Control, Two Tailed Test
Journal: Nature Cell Biology
Article Title: Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1–mucin pathway
doi: 10.1038/s41556-022-00857-4
Figure Lengend Snippet: a , b , SGCTR or GSDME -SGs- AsPC-1 or PANC-1 cells were stimulated with lysate (20 μl/ml) for 72 hr. The viable cells were measured by TB staining (a) or ATP Cell Viability Assay (b). c , d , The same as (a), except that the AsPC-1 cells were treated with IGF-II (2 ng/ml), Insulin (1 μg/ml), glucagon (0.5 ng/ml) or lysate. Cell viability was detected by TB staining (c) or ATP cell viability assay (d). e , f , SGCTR or GSDME -SGs- AsPC-1 cells were treated with lysate, DMH (10 μM), Orlistat (12.5 μM), lysate + DMH or lysate + Orlistat for 72 hr. Cell viability was determined by TB staining (e) or ATP cell viability assay (f). g , SGCTR, YBX1 -SGs-AsPC-1 cells were treated with PBS, Try/Chy or Doxorubicin (50 μM) for 48 hr. The representative images were shown. Scale bar, 20μm. h , The expression of GSDME from CCC-HPE-2, PANC-1, AsPC-1, and BxPC-3 were analyzed by western blot. i , j , CCC-HPE-2, PANC-1, AsPC-1 or BxPC-3 cells were treated with trypsin/chymotrypsin (Try/Chy) for 72 hr. Cell viability was determined by TB staining (i) or ATP cell viability assay (j). k , SGCTR and GSDME -SG-Pan02 cells (1 × 10 6 cells) were orthotopic injected into the pancreas of Prss1 −/− C57BL/6JGpt mice. 40 days after injection, tumors were presented photographically (left) and weighted (right) (n = 4). Scale bar, 1 cm. In a-f, i and j, n = 3 biological independent experiments. NS, no significance. ** P < 0.01, *** P < 0.001, by one-way ANOVA Bonferroni’s test ( a-f ) or student’s t-test ( i , j and k ). The data represent mean ± SD.
Article Snippet: The human pancreatic cancer cell lines PANC-1 (X100160), AsPC-1 (X100459) and BxPC-3 (X100441), the
Techniques: Staining, Viability Assay, Expressing, Western Blot, Injection